Skip to main content
. 2024 Mar 8;16(6):1093. doi: 10.3390/cancers16061093

Figure 2.

Figure 2

Illustration of the case of a single BSM from a melanoma without drivers’ mutation treated with one course of SRS (24 Gray to the 70% isodose line). (A): axial–sagital CT-scan and MRI slice, showing the target lesion and the patient’s dose-color-wash; (B): Dose-Volume Histogram.